Gene C2orf40, also known as ECRG4, was found that it is regulated by DNA methylation and its downregulation in ccRCC is associated with poor prognosis [18], which means ECRG4 may be a marker for ccRCC survival. This evidence concerns the gene ECRG4 and nonpapillary renal cell carcinoma.